Hikma Pharmaceutical | HIK - Bénéfice Avant Impôts

Prix De L'Action
1,322.00
Variation Quotidienne
-4.50 -0.34%
Mensuellement
8.81%
Annuel
-27.76%
Q2 Prévisions
1,279.62




Bénéfice Avant Impôts Changement Date
Almirall EUR 30.32M 22M 2025-12
argenx SE USD 386.05M 99.15M 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Autolus Therapeutics Ltd USD -91.52M 12.93M 2025-12
Bayer EUR -1.16B 735M 2025-09
Fresenius EUR 601M 122M 2025-12
Galapagos EUR -221.49M 117.07M 2025-09
Genmab DKK 55M 427M 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Orion EUR 327M 206.6M 2025-12
Recordati EUR 144.95M 25.46M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06